Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multiprofen-CC™ to Reduce Pain After Total Knee Arthroplasty
NCT06202989Phase 3Completed
- Sponsor
- KAZM Pharmaceuticals Inc.
- Start
- Sep 2024
- Primary completion
- May 2026
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of multiprofen-cc in Persistent postsurgical pain (PPSP), sponsored by KAZM Pharmaceuticals Inc.. Started Sep 2024; status: completed.
02
Drugs
multiprofen-cc
03
Conditions
Persistent postsurgical pain (PPSP)
Beyond the preview
Go deeper on NCT06202989.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06202989.